AGP Picks
View all

Airline Press Releases
Provided by AGP

Airline Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Airline Press Releases.

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

Press releases published on June 29, 2026

VOKA 3D Anatomy & Pathology Expands Free Access to the Entire 3D Model Library
Jun. 29, 2026

VOKA 3D Anatomy & Pathology Expands Free Access to the Entire 3D Model Library

Indeterminate GlobeNewswire
BrainsWay Presents Positive Data from Largest Real-World Study of Deep TMS™ in Patients with Comorbid PTSD and Major Depressive Disorder
Jun. 29, 2026

BrainsWay Presents Positive Data from Largest Real-World Study of Deep TMS™ in Patients with Comorbid PTSD and Major Depressive Disorder

Indeterminate GlobeNewswire
Kailera Therapeutics Appoints Kathleen Tregoning as Chief Corporate Affairs Officer
Jun. 29, 2026

Kailera Therapeutics Appoints Kathleen Tregoning as Chief Corporate Affairs Officer

Indeterminate GlobeNewswire
Xilio Therapeutics Appoints Ben Harshbarger as Chief Legal Officer
Jun. 29, 2026

Xilio Therapeutics Appoints Ben Harshbarger as Chief Legal Officer

Indeterminate GlobeNewswire
FreightCar America, Inc. Joins Russell 2000® and Russell 3000® Indexes
Jun. 29, 2026

FreightCar America, Inc. Joins Russell 2000® and Russell 3000® Indexes

Indeterminate GlobeNewswire
Twin Disc, Inc. Joins Russell 2000® and Russell 3000® Indexes
Jun. 29, 2026

Twin Disc, Inc. Joins Russell 2000® and Russell 3000® Indexes

Indeterminate GlobeNewswire
Palvella Therapeutics Submits First Module of Rolling New Drug Application to FDA for QTORIN™ Rapamycin for the Treatment of Microcystic Lymphatic Malformations
Jun. 29, 2026

Palvella Therapeutics Submits First Module of Rolling New Drug Application to FDA for QTORIN™ Rapamycin for the Treatment of Microcystic Lymphatic Malformations

Indeterminate GlobeNewswire
FuelCell Energy Secures $49 Million in EXIM Financing to Advance U.S. Clean Energy Exports
Jun. 29, 2026

FuelCell Energy Secures $49 Million in EXIM Financing to Advance U.S. Clean Energy Exports

Indeterminate GlobeNewswire
Tonix Pharmaceuticals Announces First Patient Enrolled in Phase 2 HORIZON Study of TNX-102 SL for the Treatment of Major Depressive Disorder (MDD)
Jun. 29, 2026

Tonix Pharmaceuticals Announces First Patient Enrolled in Phase 2 HORIZON Study of TNX-102 SL for the Treatment of Major Depressive Disorder (MDD)

Indeterminate GlobeNewswire
Forte Minerals Anchors Capital Structure with C$1.47M Treasury Influx; Highlights Tight Share Structure and Strategic Ownership Base
Jun. 29, 2026

Forte Minerals Anchors Capital Structure with C$1.47M Treasury Influx; Highlights Tight Share Structure and Strategic Ownership Base

Indeterminate GlobeNewswire
Dyadic Expands IP Protection and Business Development Activities in Japan
Jun. 29, 2026

Dyadic Expands IP Protection and Business Development Activities in Japan

Indeterminate GlobeNewswire
Martin Marietta to Combine with Lhoist North America in $13.5 Billion Transaction
Jun. 29, 2026

Martin Marietta to Combine with Lhoist North America in $13.5 Billion Transaction

Indeterminate GlobeNewswire
Gilat Receives $43 Million of Additional Sidewinder ESA Orders from Leading In-flight Connectivity Service Provider
Jun. 29, 2026

Gilat Receives $43 Million of Additional Sidewinder ESA Orders from Leading In-flight Connectivity Service Provider

Indeterminate GlobeNewswire
George Medicines appoints Brendan Walsh as Senior Vice President of Supply Chain & Technical Operations
Jun. 29, 2026

George Medicines appoints Brendan Walsh as Senior Vice President of Supply Chain & Technical Operations

Indeterminate GlobeNewswire
Field and Operations Teams Run Daily Work on Custom Power Apps
Jun. 29, 2026

Field and Operations Teams Run Daily Work on Custom Power Apps

Indeterminate GlobeNewswire
Relmada Therapeutics Joins Russell 2000® and Russell 3000® Indexes
Jun. 29, 2026

Relmada Therapeutics Joins Russell 2000® and Russell 3000® Indexes

Indeterminate GlobeNewswire
Sagimet Biosciences Joins the Russell 2000® and Russell 3000® Indexes
Jun. 29, 2026

Sagimet Biosciences Joins the Russell 2000® and Russell 3000® Indexes

Indeterminate GlobeNewswire
Vetty Named a 2026 North American Inspiring Workplace
Jun. 29, 2026

Vetty Named a 2026 North American Inspiring Workplace

Indeterminate GlobeNewswire
Agios to Host Second Quarter 2026 Financial Results Conference Call and Webcast on July 30 at 8:00 a.m. ET
Jun. 29, 2026

Agios to Host Second Quarter 2026 Financial Results Conference Call and Webcast on July 30 at 8:00 a.m. ET

Indeterminate GlobeNewswire
Satellos Receives FDA Fast Track Designation for SAT-3247 for the Treatment of Duchenne Muscular Dystrophy
Jun. 29, 2026

Satellos Receives FDA Fast Track Designation for SAT-3247 for the Treatment of Duchenne Muscular Dystrophy

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Airline Press Releases

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.